Science & Health
1 просмотров
Pfizer obesity pill delivers 15% average weight loss in phase 3 trial
Pfizer says its experimental obesity pill produced an average 15% reduction in body weight over 52 weeks in a phase 3 trial, a result that could strengthen the company’s push into the fast-growing…
4ч назад